← Leaderboards
Ragy Ramsis Girgis
New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc
$7,968,810
Attributed
$13,633,288
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,633,288 · 7
By mechanism
R01$12,348,808 · 4
R21$914,778 · 2
K23$369,702 · 1
Top collaborators
- Lawrence S Kegeles9 shared
- Dikoma C. Shungu5 shared
- Thomas Scott Stroup3 shared
- Guillermo Horga2 shared
Most similar at New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc
Same institution · by research overlap
- Guillermo Horga$11,563,576
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsPsychotic DisordersSymptomsSchizophreniaBaseHigh RiskAntipsychotic AgentsPublic HealthFuturePreventBrainFosteringCohortPathway InteractionsLeadBiological MarkersMonitorLinkNeurobiologyInsightSiteTreatment EffectResearch PersonnelMagnetic Resonance Spectroscopy
Grant awards (22)
1/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial$1,289,413
R01 · FY2025 · MH · contact PI
A Multimodal Imaging Study of Dopamine in Early Psychosis$706,228
R01 · FY2023 · MH · contact PI
1/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial$1,282,144
R01 · FY2022 · MH · contact PI
A Multimodal Imaging Study of Dopamine in Early Psychosis$742,572
R01 · FY2022 · MH · contact PI
1/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial$1,432,665
R01 · FY2021 · MH · contact PI
Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia$686,941
R01 · FY2021 · MH
The Neurobiology of Violence in a Psychosis-Risk Cohort$595,519
R01 · FY2021 · MH · contact PI
Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia$696,494
R01 · FY2020 · MH
The Neurobiology of Violence in a Psychosis-Risk Cohort$592,441
R01 · FY2020 · MH · contact PI
Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia$707,540
R01 · FY2019 · MH
The Neurobiology of Violence in a Psychosis-Risk Cohort$592,441
R01 · FY2019 · MH · contact PI
The Neurobiology of Violence in a Psychosis Risk Cohort$135,311
R01 · FY2019 · MH · contact PI
Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia$780,214
R01 · FY2018 · MH
The Neurobiology of Violence in a Psychosis-Risk Cohort$597,746
R01 · FY2018 · MH · contact PI
Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia$849,678
R01 · FY2017 · MH
The Neurobiology of Violence in a Psychosis-Risk Cohort$661,461
R01 · FY2017 · MH · contact PI
Sensory-learning deficits and conversion to psychosis among individuals at clinical high-risk: a longitudinal model-based fMRI study$202,127
R21 · FY2017 · MH · contact PI
Sensory-learning deficits and conversion to psychosis among individuals at clinical high-risk: a longitudinal model-based fMRI study$258,034
R21 · FY2016 · MH · contact PI
Multimodal MR Imaging of the Glutamate System in Schizophrenia$184,483
K23 · FY2016 · MH · contact PI
Neurochemical and Clinical Effects of Glutamate Modulation in Schizophrenia$239,841
R21 · FY2015 · MH
Multimodal MR Imaging of the Glutamate System in Schizophrenia$185,219
K23 · FY2015 · MH · contact PI
Neurochemical and Clinical Effects of Glutamate Modulation in Schizophrenia$214,776
R21 · FY2014 · MH